Plasma biomarkers to predict or rule out early post-discharge events in patients discharged after an acute heart failure hospital admission
暂无分享,去创建一个
P. Ponikowski | C. O'connor | D. J. Veldhuisen | M. Metra | J. Cleland | H. Hillege | A. Voors | D. Postmus | H. Dittrich | G. Cotter | M. Givertz | J. Teerlink | B. Davison | D. Bloomfield | B. Demissei
[1] C. O'connor,et al. Predictors and Associations With Outcomes of Length of Hospital Stay in Patients With Acute Heart Failure: Results From VERITAS. , 2016, Journal of cardiac failure.
[2] Piotr Ponikowski,et al. Patient journey after admission for acute heart failure: length of stay, 30‐day readmission and 90‐day mortality , 2016, European journal of heart failure.
[3] P. Ponikowski,et al. Use of High-Sensitivity Troponin T to Identify Patients With Acute Heart Failure at Lower Risk for Adverse Outcomes: An Exploratory Analysis From the RELAX-AHF Trial. , 2016, JACC. Heart failure.
[4] P. Ponikowski,et al. Optimizing clinical use of biomarkers in high‐risk acute heart failure patients , 2016, European journal of heart failure.
[5] J. McMurray,et al. Increased mortality with elevated plasma endothelin‐1 in acute heart failure: an ASCEND‐HF biomarker substudy , 2016, European journal of heart failure.
[6] R. D. de Boer,et al. Biomarkers and low risk in heart failure. Data from COACH and TRIUMPH , 2015, European journal of heart failure.
[7] Douglas S. Lee,et al. Assessing Risk and Preventing 30-Day Readmissions in Decompensated Heart Failure: Opportunity to Intervene? , 2015, Current Heart Failure Reports.
[8] Wing W. Chan,et al. Relation of Acute Heart Failure Hospital Length of Stay to Subsequent Readmission and All-Cause Mortality. , 2015, The American journal of cardiology.
[9] R. D. de Boer,et al. State of the Art: Newer biomarkers in heart failure , 2015, European journal of heart failure.
[10] G. Hindricks,et al. Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial , 2014, The Lancet.
[11] P. Ponikowski,et al. International differences in clinical characteristics, management, and outcomes in acute heart failure patients: better short‐term outcomes in patients enrolled in Eastern Europe and Russia in the PROTECT trial , 2014, European journal of heart failure.
[12] K. Lohr,et al. Transitional Care Interventions to Prevent Readmissions for Persons With Heart Failure , 2014, Annals of Internal Medicine.
[13] A. Voors,et al. Clinical use of novel biomarkers in heart failure: towards personalized medicine , 2014, Heart Failure Reviews.
[14] Naoki Sato,et al. Incremental value of biomarkers to clinical variables for mortality prediction in acutely decompensated heart failure: the Multinational Observational Cohort on Acute Heart Failure (MOCA) study. , 2013, International journal of cardiology.
[15] David Gur,et al. On use of partial area under the ROC curve for evaluation of diagnostic performance , 2013, Statistics in medicine.
[16] R. Califf,et al. Do Countries or Hospitals With Longer Hospital Stays for Acute Heart Failure Have Lower Readmission Rates?: Findings From ASCEND-HF , 2013, Circulation. Heart failure.
[17] R. Choudhary,et al. The Use of Biomarkers in the Patient with Heart Failure , 2013, Current Cardiology Reports.
[18] I. Piña,et al. Forecasting the Impact of Heart Failure in the United States: A Policy Statement From the American Heart Association , 2013, Circulation. Heart failure.
[19] Barry Greenberg,et al. Primary results of the HABIT Trial (heart failure assessment with BNP in the home). , 2013, Journal of the American College of Cardiology.
[20] Y. Pinto,et al. Multimarker strategy for short-term risk assessment in patients with dyspnea in the emergency department: the MARKED (Multi mARKer Emergency Dyspnea)-risk score. , 2012, Journal of the American College of Cardiology.
[21] Carl van Walraven,et al. Predicting the risk of unplanned readmission or death within 30 days of discharge after a heart failure hospitalization. , 2012, American heart journal.
[22] Alan S. Maisel,et al. Biomarkers in acute heart failure—state of the art , 2012, Nature Reviews Cardiology.
[23] H. Krumholz,et al. Telemonitoring in patients with heart failure. , 2010, The New England journal of medicine.
[24] T. Mueller,et al. Prognostic value of established and novel biomarkers in patients with shortness of breath attending an emergency department. , 2010, Clinical biochemistry.
[25] C. Yancy,et al. Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure. , 2010, JAMA.